Literature DB >> 9215320

Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men.

O T Wolf1, O Neumann, D H Hellhammer, A C Geiben, C J Strasburger, R A Dressendörfer, K M Pirke, C Kirschbaum.   

Abstract

The levels of dehydroepiandrosterone (DHEA) and its sulfate ester DHEAS decrease with age after a peak around 25 yr. Animal studies as well as the first studies in humans have generated the idea that DHEA replacement in elderly subjects may have beneficial effects on well-being and cognitive functions. In the present experiment 40 healthy elderly men and women (mean age, 69 yr) participated in a double blind, placebo-controlled DHEA substitution study. For 2 weeks subjects took 50 mg DHEA daily, followed by a 2-week wash-out period and a 2-week placebo period. The treatment sequence was randomized in a cross-over design. After 2 weeks of DHEA or placebo, psychological and physical well-being as well as cognitive performance were assessed using several questionnaires and neuropsychological tests. All subjects had low DHEAS baseline levels. DHEA substitution lead to a 5-fold increase in DHEAS levels in women (from 0.67 +/- 0.1 to 4.1 +/- 0.4 micrograms/mL; P < 0.001) and men (from 0.85 +/- 0.1 to 4.5 +/- 0.4 micrograms/mL; P < 0.001). DHEA, androstenedione, and testosterone levels also increased significantly in both sexes (all P < 0.001). No significant changes were observed in insulin-like growth factor I or insulin-like growth factor-binding protein-3 levels. DHEA replacement had no strong beneficial effect on any of the measured psychological or cognitive parameters. Only women tended to report an increase in well-being (P = 0.11) and mood (P = 0.10), as assessed with questionnaires. They also showed better performance in one of six cognitive tests (picture memory) after DHEA. However, after Bonferroni alpha adjustment, this difference was no longer significant. No such trend was observed in men (P > 0.20). Likewise, no beneficial effects of DHEA substitution could be observed in any of the other tests of the neuropsychological test battery in either sex (all P > 0.20). In conclusion, the present data do not support the idea of strong beneficial effects of a physiological DHEA substitution on well-being or cognitive performance in healthy elderly individuals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215320     DOI: 10.1210/jcem.82.7.4056

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

1.  Administration of dehydroepiandrosterone (DHEA) enhances visual-spatial performance in postmenopausal women.

Authors:  Bethany Stangl; Elliot Hirshman; Joseph Verbalis
Journal:  Behav Neurosci       Date:  2011-10       Impact factor: 1.912

2.  Adrenal steroids in adrenomyeloneuropathy. Dehydroepiandrosterone sulfate, androstenedione and 17alpha-hydroxyprogesterone.

Authors:  Maria Wichers-Rother; Andreas Grigull; Piotr Sokolowski; Birgit Stoffel-Wagner; Wolfgang Köhler
Journal:  J Neurol       Date:  2005-12       Impact factor: 4.849

Review 3.  Wishing a dream came true: DHEA as a rejuvenating treatment?

Authors:  O T Wolf; C Kirschbaum
Journal:  J Endocrinol Invest       Date:  1998-02       Impact factor: 4.256

Review 4.  Preventing cognitive decline in healthy older adults.

Authors:  Raza Naqvi; Dan Liberman; Jarred Rosenberg; Jillian Alston; Sharon Straus
Journal:  CMAJ       Date:  2013-04-15       Impact factor: 8.262

Review 5.  Genetics of androgen metabolism in women with infertility and hypoandrogenism.

Authors:  Aya Shohat-Tal; Aritro Sen; David H Barad; Vitaly Kushnir; Norbert Gleicher
Journal:  Nat Rev Endocrinol       Date:  2015-05-05       Impact factor: 43.330

Review 6.  Sex hormones and mood in the perimenopause.

Authors:  Peter J Schmidt; David R Rubinow
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

7.  Why egalitarianism might be good for your health: physiological thriving during stressful intergroup encounters.

Authors:  Wendy Berry Mendes; Heather M Gray; Rodolfo Mendoza-Denton; Brenda Major; Elissa S Epel
Journal:  Psychol Sci       Date:  2007-11

8.  Dehydroepiandrosterone sulfate and cognitive function in the elderly: The InCHIANTI Study.

Authors:  G Valenti; L Ferrucci; F Lauretani; G Ceresini; S Bandinelli; M Luci; G Ceda; M Maggio; R S Schwartz
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

Review 9.  Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.

Authors:  Sylvie Legrain; Laurence Girard
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 10.  Dehydroepiandrosterone and age-related cognitive decline.

Authors:  Krystina G Sorwell; Henryk F Urbanski
Journal:  Age (Dordr)       Date:  2009-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.